Speaker illustration

Professor Gianluigi Savarese

Karolinska Institute, Stockholm (Sweden)

Member of:

European Society of Cardiology
Heart Failure Association

Gianluigi Savarese is currently Associate Professor of Cardiology at Karolinska Institutet and Consultant for Heart Failure at the Karolinska University Hospital, Stockholm, Sweden. He received his MD from Federico II University in Naples (Italy) in 2010 and underwent cardiology residency (2011-2016) at the same Institution. In 2013-2014 he was guest fellow at the Center for Molecular Cardiology of the University of Zurich. In 2017 he got the title of heart failure specialist from the University of Zurich and the Heart Failure Association of the European Society of Cardiology. In 2018 he received his PhD from the Karolinska Institutet. He is currently Board member of the Heart Failure Association and the WG on CV pharmacotherapy of the ESC. Over the last 5 years he has published >200 scientific works on top peer-reviewed journals focusing mainly on heart failure, epidemiology and CV pharmacotherapy. He is Associate Editor for EJHF, deputy for EHJ-Open and EHJ-CR.

Industry perspective in heart failure clinical trials

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Industry Session

Thumbnail

Farewell

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Special Event

Thumbnail

Pharmacoeconomic analyses

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Symposium

Thumbnail

Closure of the day

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Special Event

Thumbnail

Welcome from the HFA Leadership and Course Organisers

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Special Event

Thumbnail

Closure of the day

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Special Event

Thumbnail

Keynote lectures

Event: HFA Clinical Trials in Heart Failure Course

Topic: Heart Failure

Session type: Symposium

Thumbnail

The new era of SGLT2 Inhibitors in Cardiovascular Disease: beyond glucose control

Event: EuroCVP 2023 – The annual meeting on advances in cardiovascular pharmacotherapy

Topic: Cardiovascular Pharmacotherapy

Session type: Teaching Course

Thumbnail

Factors detemining prognosis biomakers to scores

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session type: Rapid Fire Abstracts

Thumbnail

Addressing gender differences and ethnic disparities in heart failure

Event: Heart Failure 2023

Topic: Research Methodology

Session type: Rapid Fire Abstracts

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb